Loading clinical trials...
Loading clinical trials...
Randomized Controlled Investigator Blinded Comparative Study of the Efficacy and Tolerability of Test Product Versus Cysteamine 5% in the Treatment of Facial Epidermal Melasma Over 4 Months
Conditions
Interventions
Group TP
Group CYS
Locations
1
India
MS Clinical Research Pvt. Ltd
Bangalore, India
Start Date
October 6, 2023
Primary Completion Date
June 1, 2024
Completion Date
June 1, 2024
Last Updated
February 26, 2024
NCT06516419
NCT07296549
NCT06644157
NCT07345507
NCT06957834
NCT05326997
Lead Sponsor
Cosmetique Active International
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions